August 12, 2015
Executive Director of Clinical Research Operations
UC San Diego Health Sciences is pleased to announce Eric Mah as its first Executive Director of Clinical Research Operations. Mah is responsible for clinical research administration across Health Sciences, the clinical trials contracting project management office, the clinical research billing project management office, Clinical and Translational Research Institute (CTRI) affiliations and CTRI strategic management.
Mah, who assumed his new post on August 10, has extensive experience in research administration and compliance. Most recently, he served as senior director of research compliance at UC San Francisco and program director of regulatory, knowledge and support for UCSF's Clinical and Translational Science Institute. In these positions, including regulatory director for UC BRAID (a consortium of the five UC academic medical centers), Mah provided guidance and direction to address research compliance regulations and policies in clinical research. He was responsible for identifying emerging issues, leading projects and process efficiency redesigns, coordinating internal and external communications, and ensuring that regulatory matters were managed in a timely and appropriate way.
At UC San Diego, Mah will help lead strategic initiatives to attract clinical research, build and foster key internal and external relationships, and facilitate rapid study initiation by simplifying processes in an ever-changing and increasingly complex regulatory landscape. In addition, he will work closely with the CTRI team, the Human Research Protections Program, the Office of Clinical Trial Administration, and the Office of Coverage Analysis Administration, to coordinate efforts to enhance the clinical research program at UC San Diego.
"We are delighted that Eric has joined UC San Diego in this new role created to integrate multiple steps needed to initiate and perform clinical trials. With his help, research units will hopefully see tangible improvement when navigating the complex regulatory path," said Gary S. Firestein, MD, dean and associate vice chancellor of translational medicine.
Mah has also held leadership positions in research administration, compliance, and the Institutional Review Board at UC Davis and UCLA. He is a regular speaker at national conferences and has presented to governmental advisory and legislative committees on human research protections, research compliance, and integrity issues. Mah received a master's degree from the Johns Hopkins School of Public Health and a bachelor's degree in philosophy in ethics from UCLA.